Advance Auto Parts, Inc. (AAP) Decline: Is It Certain
ROTH MKM has recently resumed Advance Auto Parts, Inc. (AAP) stock to Neutral rating, as announced on October 16, 2024, according to Finviz. Earlier, on October 15, 2024, Wedbush had raised the stock from a Neutral to Outperform, setting a price target of $55. Mizuho also initiated Neutral rating with a price target of $78. […]
Stem Inc (STEM) Shock: Unpacking Today’s Price Drop
Susquehanna has recently reduced Stem Inc (STEM) stock to Neutral rating, as announced on August 9, 2024, according to Finviz. Earlier, on August 7, 2024, TD Cowen had reduced the stock from a Buy to Hold, setting a price target of $1 for STEM stock. Goldman also reduced Neutral rating with a price target of […]
Altice USA Inc (ATUS)’s Stock Plunge: What You Need to Know
UBS has recently reduced Altice USA Inc (ATUS) stock to Neutral rating, as announced on August 2, 2024, according to Finviz. Earlier, on July 1, 2024, Goldman had initiated the stock to Sell, setting a price target of $2. BofA Securities also resumed Underperform rating with a price target of $1.50. Additionally, JP Morgan reduced […]
NKTX’s Unexpected Plunge: What’s Next?
Rodman & Renshaw has recently initiated Nkarta Inc (NKTX) stock to Buy rating, as announced on October 9, 2024, according to Finviz. Earlier, on August 14, 2024, Raymond James had raised the stock from a Outperform to Strong Buy, setting a price target of $16. Raymond James also reduced Outperform rating with a price target […]
Clean Energy Fuels Corp (CLNE) Stock Dive: The Hidden Causes Revealed
Raymond James has recently raised Clean Energy Fuels Corp (CLNE) stock to Strong Buy rating, as announced on October 3, 2023, according to Finviz. Earlier, on September 5, 2023, Northland Capital had initiated the stock to Outperform, setting a price target of $7.50. Stifel also initiated Buy rating with a price target of $6. Additionally, […]
VSTM’s Latest Surge: What’s Behind the Spike?
Guggenheim has recently initiated Verastem Inc (VSTM) stock to Buy rating, as announced on September 30, 2024, according to Finviz. Earlier, on November 21, 2023, BTIG Research had resumed the stock to Buy, setting a price target of $27. B. Riley Securities also initiated Buy rating with a price target of $21. Additionally, Mizuho raised […]
The Ondas Holdings Inc Stock Thriller: Decoding the Mystery Behind ONDS’s Recent Movements
Ladenburg Thalmann has recently initiated Ondas Holdings Inc (ONDS) stock to Buy rating, as announced on December 11, 2023, according to Finviz. Earlier, on February 16, 2021, Northland Capital had initiated the stock to Outperform, setting a price target of $22. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor […]
FBIO’s Latest Twist: What’s Fueling the Unexpected Shifts in Fortress Biotech Inc’s Stock Price?
ROTH MKM has recently resumed Fortress Biotech Inc (FBIO) stock to Buy rating, as announced on March 15, 2024, according to Finviz. Earlier, on August 4, 2022, Ladenburg Thalmann had initiated the stock to Buy, setting a price target of $6. The Benchmark Company also initiated Buy rating with a price target of $9. Additionally, […]
Voyager Therapeutics Inc (VYGR) Stock Dilemma: A Surge That Has Everyone Talking—What’s the Real Story?
Wedbush has recently resumed Voyager Therapeutics Inc (VYGR) stock to Outperform rating, as announced on November 29, 2024, according to Finviz. Earlier, on October 16, 2024, Leerink Partners had initiated the stock to Outperform, setting a price target of $15. Guggenheim also initiated Buy rating with a price target of $22. Additionally, H.C. Wainwright initiated […]
The CYCC Conundrum: Why Cyclacel Pharmaceuticals Inc’s Stock Is Making Headlines Again
Oppenheimer has recently resumed Cyclacel Pharmaceuticals Inc (CYCC) stock to Outperform rating, as announced on July 18, 2022, according to Finviz. Earlier, on April 27, 2020, ROTH Capital had resumed the stock to Buy, setting a price target of $24. Ladenburg Thalmann also initiated Buy rating. Additionally, H.C. Wainwright initiated Buy rating on October 16, […]